These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34558836)
1. Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple. Yuan L; McCommis KS; Neuschwander-Tetri BA Hepatol Commun; 2022 Nov; 6(11):3003-3005. PubMed ID: 34558836 [No Abstract] [Full Text] [Related]
2. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism. Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936 [TBL] [Abstract][Full Text] [Related]
3. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies. Ozasa H; Ayaori M; Iizuka M; Terao Y; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Uehara Y; Ogura M; Sasaki M; Komatsu T; Horii S; Mochizuki S; Yoshimura M; Ikewaki K Atherosclerosis; 2011 Nov; 219(1):141-50. PubMed ID: 21862012 [TBL] [Abstract][Full Text] [Related]
4. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs. Lee MA; Tan L; Yang H; Im YG; Im YJ Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903 [TBL] [Abstract][Full Text] [Related]
5. Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease. Fernandez-Boyanapalli RF; Frasch SC; Thomas SM; Malcolm KC; Nicks M; Harbeck RJ; Jakubzick CV; Nemenoff R; Henson PM; Holland SM; Bratton DL J Allergy Clin Immunol; 2015 Feb; 135(2):517-527.e12. PubMed ID: 25498313 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia. Izawa Y; Takahashi S; Suzuki N Brain Res; 2009 Dec; 1305():64-73. PubMed ID: 19800324 [TBL] [Abstract][Full Text] [Related]
7. 5-Benzylidene, 5-benzyl, and 3-benzylthiazolidine-2,4-diones as potential inhibitors of the mitochondrial pyruvate carrier: Effects on mitochondrial functions and survival in Drosophila melanogaster. Touaibia M; St-Coeur PD; Duff P; Faye DC; Pichaud N Eur J Pharmacol; 2021 Dec; 913():174627. PubMed ID: 34774497 [TBL] [Abstract][Full Text] [Related]
8. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}. Subramanian V; Golledge J; Ijaz T; Bruemmer D; Daugherty A Circ Res; 2010 Oct; 107(8):953-8. PubMed ID: 20798360 [TBL] [Abstract][Full Text] [Related]
9. Pioglitazone inhibits EGFR/MDM2 signaling-mediated PPARγ degradation. Shi J; Zhang W; You M; Xu Y; Hou Y; Jin J Eur J Pharmacol; 2016 Nov; 791():316-321. PubMed ID: 27614128 [TBL] [Abstract][Full Text] [Related]
10. Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis. Zeissler ML; Eastwood J; McCorry K; Hanemann CO; Zajicek JP; Carroll CB Oncotarget; 2016 Jul; 7(29):46603-46614. PubMed ID: 27366949 [TBL] [Abstract][Full Text] [Related]
11. Pioglitazone, PPARγ agonist, attenuates experimental autoimmune neuritis. Ramkalawan H; Wang YZ; Hurbungs A; Yang YF; Tian FF; Zhou WB; Li J; Yang H; Xiao B; Zhang W Inflammation; 2012 Aug; 35(4):1338-47. PubMed ID: 22389055 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone alleviates the mitochondrial apoptotic pathway and mito-oxidative damage in the d-galactose-induced mouse model. Prakash A; Kumar A Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):644-51. PubMed ID: 23795773 [TBL] [Abstract][Full Text] [Related]
13. Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells. Saad S; Zhang J; Yong R; Yaghobian D; Wong MG; Kelly DJ; Chen XM; Pollock CA Diabetologia; 2013 May; 56(5):1174-82. PubMed ID: 23370527 [TBL] [Abstract][Full Text] [Related]
14. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Caglayan E; Stauber B; Collins AR; Lyon CJ; Yin F; Liu J; Rosenkranz S; Erdmann E; Peterson LE; Ross RS; Tangirala RK; Hsueh WA Diabetes; 2008 Sep; 57(9):2470-9. PubMed ID: 18511847 [TBL] [Abstract][Full Text] [Related]
15. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism. Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035 [TBL] [Abstract][Full Text] [Related]
16. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation. Liu LP; Yan TH; Jiang LY; Hu W; Hu M; Wang C; Zhang Q; Long Y; Wang JQ; Li YQ; Hu M; Hong H Acta Pharmacol Sin; 2013 Apr; 34(4):455-63. PubMed ID: 23524568 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression. Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575 [TBL] [Abstract][Full Text] [Related]
18. Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome. Mrówka P; Głodkowska E; Młynarczuk-Biały I; Biały L; Kuckelkorn U; Nowis D; Makowski M; Legat M; Gołab J Acta Biochim Pol; 2008; 55(1):75-84. PubMed ID: 18327303 [TBL] [Abstract][Full Text] [Related]
19. Activation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues. Koh YJ; Park BH; Park JH; Han J; Lee IK; Park JW; Koh GY Exp Mol Med; 2009 Dec; 41(12):880-95. PubMed ID: 19745605 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo. Al-Taie OH; Graf T; Illert B; Katzenberger T; Mörk H; Kraus MR; Barthelmes HU; Scheurlen M; Seufert J J Gastroenterol; 2009; 44(9):919-29. PubMed ID: 19506796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]